GEODE CAPITAL MANAGEMENT, LLC

Position in ADTX — Aditxt, Inc.

CIK 1214717 BOSTON, MA

Position in ADTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$11,473

+$683 QoQ

Shares Held

434

+43300.0% QoQ

Ownership

0.053%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 9 holders

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,017,848	$2,989,245,636
2	REGN	Regeneron Pharmaceuticals, Inc.	2,625,810	$1,637,297,566
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,635,840	$793,466,914
4	RVMD	Revolution Medicines, Inc.	3,942,676	$738,384,360
5	MRNA	Moderna, Inc.	9,710,335	$680,014,759
6	INCY	Incyte Corp	4,750,735	$538,543,319
7	RPRX	Royalty Pharma plc	8,058,048	$451,814,751
8	INSM	INSMED Inc	4,220,155	$449,952,925

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$11,473	11,721	-18.3%	Shares	Defined	2026-05-15
2025-09-30	$10,790	14,350	-18.9%	Shares	Defined	2025-11-12
2024-09-30	—	17,697	+56.3%	Shares	Defined	2024-11-12
2024-06-30	—	11,325	-21.8%	Shares	Defined	2024-08-09
2024-03-31	—	14,487	-93.4%	Shares	Defined	2024-05-13
2022-06-30	—	217,991	+18.9%	Shares	Defined	2022-08-12
2022-03-31	—	183,265	+2.9%	Shares	Defined	2022-05-13
2021-12-31	—	178,043	-11.3%	Shares	Defined	2022-02-11
2021-09-30	—	200,622	+118.0%	Shares	Defined	2021-11-12
2021-06-30	—	92,015	+12.5%	Shares	Defined	2021-08-13
2021-03-31	—	81,786	—	Shares	Defined	2021-05-12
No filing history on record for this holder in this stock.